Literature DB >> 1972211

Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis.

G Santis1, L Osborne, R A Knight, M E Hodson.   

Abstract

The frequencies of the delta F508 mutation and haplotypes at the loci linked to the cystic fibrosis (CF) gene have been compared in adult CF patients with very mild and with severe lung disease. In patients who are compound heterozygotes for the delta F508 mutation, or who lack the mutation on both chromosomes, the as yet undefined mutations may influence the severity of lung involvement. In patients homozygous for the delta F508 mutation, non-genetic factors cannot fully account for variation in the severity of lung disease. Genes outside the CF locus may influence clinical expression of the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972211     DOI: 10.1016/0140-6736(90)91448-j

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene.

Authors:  L Osborne; G Santis; M Schwarz; K Klinger; T Dörk; I McIntosh; M Schwartz; V Nunes; M Macek; J Reiss
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

2.  Peak oxygen uptake and mortality in children with cystic fibrosis.

Authors:  P Pianosi; J Leblanc; A Almudevar
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

3.  A mutation in the second nucleotide binding fold of the cystic fibrosis gene.

Authors:  L Osborne; R Knight; G Santis; M Hodson
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

4.  Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.

Authors:  R B Parad; C J Gerard; D Zurakowski; D P Nichols; G B Pier
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 5.  Recent advances in cystic fibrosis research.

Authors:  R Dinwiddie; O Crawford
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

6.  Cystic fibrosis presenting as hyponatraemic heat exhaustion.

Authors:  H R Smith; G S Dhatt; W M Melia; J G Dickinson
Journal:  BMJ       Date:  1995-03-04

7.  Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.

Authors:  D Gosselin; J DeSanctis; M Boulé; E Skamene; C Matouk; D Radzioch
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 8.  Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.

Authors:  Ankit A Desai; Pirro Hysi; Joe G N Garcia
Journal:  Transl Res       Date:  2007-12-18       Impact factor: 7.012

9.  Severity of chest disease in cystic fibrosis patients in relation to their genotypes.

Authors:  L N al-Jader; A L Meredith; H C Ryley; J P Cheadle; S Maguire; G Owen; M C Goodchild; P S Harper
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

10.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.